But I feel like that's, you know, trying to create those new traditions
AstraZenecas recent FDA approval for Baxfendy feels like another reminder that big pharma is still doubling down on chronic disease spaces where the commercial opportunity is large, but the operational and development complexity is also very high
Figure 4 shows the mechanism of some of the passive loading and active loading methods in liposomes
This article outlines how to assess and describe skin lesions, then gives an overview of common lesions, under the categories of pigmented and non-pigmented, aiming for familiarity with the common types for a GDP readership, rather than a comprehensive review
Following this initial period, it shifts to $897 for a 12-week recurring subscription (this means you pay $299 per month)
Hair loss telogen effluvium